Phraction Management LLC Invests $6.37 Million in Synopsys, Inc. $SNPS
by Kim Johansen · The Markets DailyPhraction Management LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the third quarter, HoldingsChannel.com reports. The institutional investor bought 12,913 shares of the semiconductor company’s stock, valued at approximately $6,371,000. Synopsys makes up approximately 1.8% of Phraction Management LLC’s investment portfolio, making the stock its 18th largest position.
A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in shares of Synopsys by 1.6% during the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock valued at $7,721,363,000 after purchasing an additional 231,014 shares in the last quarter. State Street Corp raised its position in Synopsys by 1.2% in the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after purchasing an additional 85,662 shares during the period. Geode Capital Management LLC lifted its stake in shares of Synopsys by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock worth $1,810,214,000 after acquiring an additional 51,043 shares during the last quarter. Ameriprise Financial Inc. lifted its position in shares of Synopsys by 29.1% during the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in Synopsys by 10.9% in the 2nd quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock worth $980,757,000 after acquiring an additional 187,790 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares of the company’s stock, valued at $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.62% of the stock is owned by company insiders.
Synopsys Stock Up 1.1%
Shares of SNPS opened at $458.13 on Friday. The company’s 50-day simple moving average is $433.69 and its 200-day simple moving average is $503.75. The stock has a market capitalization of $85.10 billion, a PE ratio of 57.34, a P/E/G ratio of 3.77 and a beta of 1.16. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company’s revenue was up 37.8% on a year-over-year basis. During the same period last year, the business earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of research analysts have commented on SNPS shares. Needham & Company LLC raised their target price on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Stifel Nicolaus lowered their price target on Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Baird R W lowered shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Finally, Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and lowered their price objective for the stock from $605.00 to $560.00 in a research report on Tuesday, December 9th. Eleven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus target price of $562.13.
Read Our Latest Stock Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Conference Calls and Individual Investors
- Qualcomm’s Monster Rally Has a Catch—Can the Stock Keep Climbing?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Forget the Chips: 4 Industrial Plays for the AI Rebound
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).